A comprehensive update on the potential of curcumin to enhance chemosensitivity in colorectal cancer

Tools

Shadnoush, Mahdi and Momenan, Mehrnaz and Seidel, Veronique and Tierling, Sascha and Fatemi, Nayeralsadat and Nazemalhosseini-Mojarad, Ehsan and Norooz, Mohammad Tayefeh and Cheraghpour, Makan (2024) A comprehensive update on the potential of curcumin to enhance chemosensitivity in colorectal cancer. Pharmacological Reports. ISSN 1734-1140 (https://doi.org/10.1007/s43440-024-00652-y)

[thumbnail of Shadnoush-etal-PR-2024-A-comprehensive-update-on-the-potential-of-curcumin-to-enhance-chemosensitivity]
Preview
 Text. Filename: Shadnoush-etal-PR-2024-A-comprehensive-update-on-the-potential-of-curcumin-to-enhance-chemosensitivity.pdf
Accepted Author Manuscript
License: Creative Commons Attribution 4.0 logo
Download (1MB)| Preview

Abstract

Colorectal cancer (CRC) is one of the most common cancers and a major cause of cancer-related mortality worldwide. The efficacy of chemotherapy agents in CRC treatment is often limited due to toxic side effects, heterogeneity of cancer cells, and the possibility of chemoresistance which promotes cancer cell survival through several mechanisms. Combining chemotherapy agents with natural compounds like curcumin, a polyphenol compound from the Curcuma longa plant, has been reported to overcome chemoresistance and increase the sensitivity of cancer cells to chemotherapeutics. Curcumin, alone or in combination with chemotherapy agents, has been demonstrated to prevent chemoresistance by modulating various signaling pathways, reducing the expression of drug resistance-related genes. The purpose of this article is to provide a comprehensive update on studies that have investigated the ability of curcumin to enhance the efficacy of chemotherapy agents used in CRC. It is hoped that it can serve as a template for future research on the efficacy of curcumin, or other natural compounds, combined with chemotherapy agents to maximize the effectiveness of therapy and reduce the side effects that occur in CRC or other cancers.

ORCID iDs

Shadnoush, Mahdi, Momenan, Mehrnaz, Seidel, Veronique ORCID logoORCID: https://orcid.org/0000-0003-3880-5261, Tierling, Sascha, Fatemi, Nayeralsadat, Nazemalhosseini-Mojarad, Ehsan, Norooz, Mohammad Tayefeh and Cheraghpour, Makan;

Persistent Identifier

https://doi.org/10.17868/strath.00090946
CORE (COnnecting REpositories)